Clincosm LogoSign in Get a demo

chronic hepatitis c

Showing 26 - 50 of 351
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)

Completed
Has Results
  • Chronic Hepatitis C
  • Baltimore, Maryland
    Institute of Human Virology University of Maryland
Apr 26, 2021

Chronic Hepatitis C Trial (Danoprevir, Ritonavir, peginterferon alfa-2a)

Completed
Has Results
  • Chronic Hepatitis C
  • (no location specified)
Feb 28, 2021

Chronic Hepatitis c, Liver Transplant Infection, Kidney Transplant Infection Trial in Taichung (grazoprevir 100 mg/ elbasvir 50

Terminated
  • Chronic Hepatitis c
  • +2 more
  • grazoprevir 100 mg/ elbasvir 50 mg, Zepatier®
  • Taichung, Taiwan
  • +1 more
Mar 14, 2021

Liver Cirrhosis, Chronic Hepatitis C Trial in Philadelphia (Rifaximin, Placebo)

Terminated
  • Liver Cirrhosis
  • Chronic Hepatitis C
  • Philadelphia, Pennsylvania
    Philadelphia VA Medical Center
Mar 8, 2021

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)

Completed
Has Results
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Trial in Cairo (Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin, Sofosbuvir /

Recruiting
  • Chronic Hepatitis C
  • Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin
  • Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
  • Cairo, Egypt
    Faculty of medicine Helwan University
Jan 3, 2021

Chronic Hepatitis C Trial in Tokyo (Albinterferon alfa 2b)

Completed
  • Chronic Hepatitis C
  • Albinterferon alfa 2b
  • Tokyo, Japan
    Novartis Pharmaceuticals, Japan
Dec 6, 2020

Chronic Hepatitis C Trial in Changchun (HEC74647, HEC110114)

Completed
  • Chronic Hepatitis C
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Nov 4, 2020

Chronic Hepatitis C Trial (Ravidasvir, Danoprevir, Ritonavir)

Completed
Has Results
  • Chronic Hepatitis C
  • (no location specified)
Oct 20, 2020

Chronic Hepatitis C Trial in San Francisco (modified directly observed therapy (mDOT), unobserved dosing, Motivational

Completed
  • Chronic Hepatitis C
  • modified directly observed therapy (mDOT)
  • +2 more
  • San Francisco, California
    Substance Use Research Unit
Oct 20, 2020

Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and

Completed
  • Liver Cirrhoses
  • +2 more
  • Vitamin B12 and Folic Acid
  • Assiut, Egypt
    Mohamed Shaban Redwan Helal
Oct 14, 2020

Chronic Hepatitis C Trial in Jilin (HEC110114 Tablet, Sofosbuvir Tablet)

Completed
  • Chronic Hepatitis C
  • HEC110114 Tablet
  • Sofosbuvir Tablet
  • Jilin, Changchun, China
    The First Hospital of Jilin University
Sep 9, 2020

Chronic Hepatitis C Trial in Taiwan (JKB-122 5mg, JKB-122 15mg, JKB-122 35mg)

Terminated
  • Chronic Hepatitis C
  • JKB-122 5mg
  • +3 more
  • Changhua, Taiwan
  • +13 more
Jul 19, 2020

Chronic Hepatitis C Trial run by the NIDDK (Chlorcyclizine HCl, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 29, 2020

Chronic Hepatitis c, Cirrhosis, Liver, Fibrosis, Liver Trial in United States (Peginterferon alfa-2a + Ribavirin, Peginterferon

Completed
Has Results
  • Chronic Hepatitis c
  • +3 more
  • Peginterferon alfa-2a + Ribavirin
  • Peginterferon alfa-2a
  • Long Beach, California
  • +10 more
Apr 29, 2020

Hepatitis C, Hepatitis C, Chronic, Chronic Hepatitis C Trial in Antwerp, Phoenix, Chisinau (AT-527, Daclatasvir)

Completed
  • Hepatitis C
  • +4 more
  • Antwerp, Belgium
  • +2 more
May 1, 2020

Hepatitis C Patients Treated With Peginterferon Alpha-2a and

Completed
  • Chronic Hepatitis C
  • chronic hepatitis C
  • Seoul, Korea, Republic of
  • +1 more
Mar 19, 2020

Chronic Hepatitis C Trial run by the NIDDK (Sofosbuvir, GS-5816)

Completed
Has Results
  • Chronic Hepatitis C
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2020

Chronic Hepatitis c Trial in Changchun (Kangdaprevir Sodium Tablet, )

Completed
  • Chronic Hepatitis c
  • Kangdaprevir Sodium Tablet
  • placebo
  • Changchun, Jilin, China
    the First Hospital of Jilin University
Mar 17, 2020

Chronic Hepatitis C Trial in Changchun (HEC74647PA capsule, )

Completed
  • Chronic Hepatitis C
  • HEC74647PA capsule
  • placebo
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Mar 17, 2020

Chronic Hepatitis c Trial in Changchun (HEC74647PA Capsule, )

Completed
  • Chronic Hepatitis c
  • HEC74647PA Capsule
  • placebo
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Mar 17, 2020

Chronic Hepatitis C Trial in Changchun (HEC110114 tablet, Placebo Oral Tablet)

Completed
  • Chronic Hepatitis C
  • HEC110114 tablet
  • Placebo Oral Tablet
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Mar 16, 2020